<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://www.massachusettsweekly.com/article/907153982-ekaru-awarded-gtia-cybersecurity-trustmark-for-excellence-in-cybersecurity-practices</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T18:11:37+00:00</news:publication_date>
        <news:title>Ekaru Awarded GTIA Cybersecurity Trustmark for Excellence in Cybersecurity Practices</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24837480-gtia-cybersecurity-trustmark-as-1080x1080.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/906796138-aptia-earns-gold-in-the-2026-hermes-creative-awards-for-event-marketing-campaign-at-hr-tech</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T14:00:00+00:00</news:publication_date>
        <news:title>Aptia Earns Gold in the 2026 Hermes Creative Awards for Event Marketing Campaign at HR Tech</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/23790683-aptia-logo-223x226.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/906817046-uplizd-inc-launches-unified-infrastructure-for-enterprise-grade-agentic-ai</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T14:00:00+00:00</news:publication_date>
        <news:title>Uplizd, Inc. Launches Unified Infrastructure for Enterprise-Grade Agentic AI</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24835855-uplizd-unified-infrastructure-880x1211.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/906937548-the-new-england-center-for-children-celebrates-susan-langer-as-boston-red-sox-most-valuable-educator-honoree</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T13:15:00+00:00</news:publication_date>
        <news:title>The New England Center for Children Celebrates Susan Langer as Boston Red Sox ‘Most Valuable Educator’ Honoree</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24836207-langer-with-wally-at-red-sox-4032x3024.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/905898579-bookbud-ai-relaunches-with-enhanced-ai-book-creation-and-integrated-global-distribution</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T13:00:00+00:00</news:publication_date>
        <news:title>BookBud.ai Relaunches with Enhanced AI Book Creation and Integrated Global Distribution</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24833426-bookbud-ai-hp-1-202604151356-2400x1350.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/906095998-authorvoices-ai-relaunches-with-ai-mastering-engine-that-delivers-pro-quality-audiobooks-in-under-an-hour</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T13:00:00+00:00</news:publication_date>
        <news:title>AuthorVoices.ai Relaunches with AI Mastering Engine That Delivers Pro Quality Audiobooks in Under an Hour</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24834259-authorvoices-ai-hp-2-2026041612-2400x1350.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/906101620-selfpublishing-pro-relaunches-with-ai-powered-tools-for-authors-to-create-publish-and-market-books</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T13:00:00+00:00</news:publication_date>
        <news:title>SelfPublishing.pro Relaunches with AI-Powered Tools for Authors to Create, Publish, and Market Books</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24834307-selfpublishing-pro-hp-3-2026041-2400x1350.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/906111128-ai-book-editing-surpasses-most-professional-editors-new-service-demonstrates-breakthrough</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T13:00:00+00:00</news:publication_date>
        <news:title>AI Book Editing Surpasses Most Professional Editors, New Service Demonstrates Breakthrough</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24834372-bookeditor-io-hp-4-202604161359-2400x1350.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/906136441-ai-powered-platform-generates-fully-custom-children-s-books-from-uploaded-photos-in-minutes</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T13:00:00+00:00</news:publication_date>
        <news:title>AI-Powered Platform Generates Fully Custom Children&#39;s Books From Uploaded Photos in Minutes</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24834522-starringmykid-com-hp-5-20260416-2400x1350.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/906319258-ai-book-trailer-platform-cuts-production-time-from-weeks-to-minutes-at-fraction-of-traditional-cost</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T13:00:00+00:00</news:publication_date>
        <news:title>AI Book Trailer Platform Cuts Production Time from Weeks to Minutes at Fraction of Traditional Cost</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24835269-bookreelz-com-hp-6-202604171540-2400x1350.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/906507117-walkpunch-launches-ai-powered-punch-list-tool-that-converts-job-site-videos-into-trade-sorted-action-items</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T13:00:00+00:00</news:publication_date>
        <news:title>WalkPunch Launches AI-Powered Punch List Tool That Converts Job-Site Videos Into Trade-Sorted Action Items</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24835614-walkpunch-com-hp-7-202604181211-2400x1350.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/901556457-sba-financed-internal-ownership-transitions-gain-momentum-among-engineering-firms-nationwide</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T12:00:00+00:00</news:publication_date>
        <news:title>SBA-Financed Internal Ownership Transitions Gain Momentum Among Engineering Firms Nationwide</news:title>
      </news:news>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907010128-national-shattering-silence-coalition-calls-for-urgent-reform-after-preventable-psychiatric-system-failure-in-alabama</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T12:00:00+00:00</news:publication_date>
        <news:title>National Shattering Silence Coalition Calls for Urgent Reform After Preventable Psychiatric System Failure in Alabama</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24836807-river-hammett-656x336.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907230798-curiox-biosystems-signs-master-software-license-agreement-for-enterprise-scale-pluto-code-deployment</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-22T00:00:00+00:00</news:publication_date>
        <news:title>Curiox Biosystems Signs Master Software License Agreement for Enterprise-Scale Pluto Code Deployment</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2faf597f-471d-45ee-a32f-fdf0ed764592/small/curiox-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907120116-tropigas-modernizes-mission-critical-energy-operations-with-creatio</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T11:34:41+00:00</news:publication_date>
        <news:title>Tropigas Modernizes Mission-Critical Energy Operations with Creatio</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24837164-tropigas-1200x628.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907207199-liberty-defense-announces-pricing-of-its-u-s-initial-public-offering</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T21:18:47+00:00</news:publication_date>
        <news:title>Liberty Defense Announces Pricing of its U.S. Initial Public Offering</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e3680d7e-614f-4715-8d2b-337dbd073cbc/small/liberty-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907207103-aktis-oncology-announces-presentation-of-first-clinical-imaging-and-dosimetry-data-for-aky-2519-at-the-2026-american-society-of-clinical-oncology</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T21:00:00+00:00</news:publication_date>
        <news:title>Aktis Oncology Announces Presentation of First Clinical Imaging and Dosimetry Data for AKY-2519 at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/490bbb9a-2b27-4a72-8d7a-333387326d8b/small/aktis-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907195728-rgenta-therapeutics-announces-rgt-61159-clinical-poster-presentation-at-the-upcoming-2026-american-society-of-clinical-oncology-asco-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T20:30:00+00:00</news:publication_date>
        <news:title>Rgenta Therapeutics Announces RGT-61159 Clinical Poster Presentation at the Upcoming 2026 American Society of Clinical Oncology (ASCO) Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/de2f6450-22c4-4c16-b785-04cea917de03/small/rgenta-logo-fullcolor-print-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907197468-aspen-aerogels-provides-east-providence-facility-update</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T20:30:00+00:00</news:publication_date>
        <news:title>Aspen Aerogels Provides East Providence Facility Update</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d9832b9e-3339-4760-9351-f988900fc3b9/small/aspn-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907198302-rapport-therapeutics-presents-rap-219-focal-onset-seizure-phase-2a-follow-up-period-results-demonstrating-sustained-seizure-reduction-at-the-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T20:30:00+00:00</news:publication_date>
        <news:title>Rapport Therapeutics Presents RAP-219 Focal Onset Seizure Phase 2a Follow-up Period Results Demonstrating Sustained Seizure Reduction at the 2026 American Academy of Neurology Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7777ee9b-f88b-4a59-a668-d81520f9d32c/small/rapport-logo-color-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907195040-foghorn-therapeutics-presents-new-preclinical-data-for-selective-smarca2-inhibitor-fhd-909-and-for-selective-cbp-ep300-and-arid1b-degrader-programs</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T20:05:00+00:00</news:publication_date>
        <news:title>Foghorn Therapeutics Presents New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and for Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/742c7e36-c026-4cb2-b89a-933512e66fea/small/foghorn-logo-color-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907195631-immuneering-to-present-new-survival-data-from-first-line-pancreatic-cancer-patients-treated-with-atebimetinib-mgnp-in-an-oral-presentation-at-the</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T20:05:00+00:00</news:publication_date>
        <news:title>Immuneering to Present New Survival Data from First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP in an Oral Presentation at the 2026 ASCO Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/81d0c83f-ae53-4d6e-9c5e-d6963e02f29d/small/immuneering-logo-cropped-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907194936-beta-bionics-announces-first-quarter-2026-financial-results-and-raises-full-year-2026-guidance</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T20:03:00+00:00</news:publication_date>
        <news:title>Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/88df4d95-789c-467a-8481-f67e19e1adfa/small/beta-bionics-logo-2color-1200-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907195777-wave-life-sciences-announces-hearing-on-proposed-redomiciliation-to-the-united-states</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T20:01:00+00:00</news:publication_date>
        <news:title>Wave Life Sciences Announces Hearing on Proposed Redomiciliation to the United States</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b2c5e218-8ae8-4dc2-b6f2-cf55b6b3b6e0/small/wave-life-sciences-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907183356-precede-biosciences-launches-precede-bio-insight-a-genome-wide-liquid-biopsy-for-functional-tumor-biology-at-aacr-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T18:30:00+00:00</news:publication_date>
        <news:title>Precede Biosciences Launches Precede Bio Insight™, a Genome-Wide Liquid Biopsy for Functional Tumor Biology at AACR 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/adc7102a-f715-445b-9532-23260281465e/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907173076-ai-enhanced-medical-ventilators-drive-healthcare-digitization-as-investment-in-respiratory-care-technology-surges</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T17:43:52+00:00</news:publication_date>
        <news:title>AI-Enhanced Medical Ventilators Drive Healthcare Digitization as Investment in Respiratory Care Technology Surges</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907163801-anaqua-establece-un-nuevo-est-ndar-de-protecci-n-de-marca-moderna-con-soluciones-impulsadas-por-ia</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T16:40:13+00:00</news:publication_date>
        <news:title>Anaqua establece un nuevo estándar de protección de marca moderna con soluciones impulsadas por IA</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907163814</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T16:40:13+00:00</news:publication_date>
        <news:title>אנאקווה קובעת סטנדרט חדש להגנה מודרנית על מותגים עם פתרונות מבוססי בינה מלאכותית</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907163817-ai</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T16:40:13+00:00</news:publication_date>
        <news:title>アナクア、AI駆動型ソリューションで、現代のブランド保護の新基準を打ち立てる</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907163843-anaqua-setzt-mit-ki-gest-tzten-l-sungen-neue-ma-st-be-f-r-modernen-markenschutz</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T16:40:13+00:00</news:publication_date>
        <news:title>Anaqua setzt mit KI-gestützten Lösungen neue Maßstäbe für modernen Markenschutz</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907163857-anaqua-menetapkan-standard-baharu-bagi-perlindungan-jenama-moden-melalui-penyelesaian-dipacu-ai</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T16:40:13+00:00</news:publication_date>
        <news:title>Anaqua Menetapkan Standard Baharu bagi Perlindungan Jenama Moden melalui Penyelesaian Dipacu AI</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907163867-anaqua-tablit-une-nouvelle-norme-en-mati-re-de-protection-moderne-des-marques-gr-ce-des-solutions-optimis-es-par-l-ia</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T16:40:13+00:00</news:publication_date>
        <news:title>Anaqua établit une nouvelle norme en matière de protection moderne des marques grâce à des solutions optimisées par l’IA</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907163881-anaqua-ai</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T16:40:13+00:00</news:publication_date>
        <news:title>Anaqua 以 AI 驱动型解决方案树立现代品牌保护新标杆</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907163887-anaqua</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T16:40:13+00:00</news:publication_date>
        <news:title>Anaqua 運用人工智能驅動的解決方案，為現代品牌保護訂立新標準</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907163922-anaqua-ai</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T16:40:13+00:00</news:publication_date>
        <news:title>Anaqua, AI 기반 솔루션으로 현대적 브랜드 보호의 새로운 기준 제시</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907163951-anaqua-cria-novo-padr-o-de-prote-o-moderna-de-marca-com-solu-es-orientadas-por-ia</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T16:40:13+00:00</news:publication_date>
        <news:title>Anaqua Cria Novo Padrão de Proteção Moderna de Marca com Soluções Orientadas por IA</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907153772-northeast-bank-announces-dates-for-fiscal-2026-third-quarter-earnings-results-and-conference-call</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T15:00:00+00:00</news:publication_date>
        <news:title>Northeast Bank Announces Dates for Fiscal 2026 Third Quarter Earnings Results and Conference Call</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ec44d25b-c247-4d5d-9264-10fb03e30aa8/small/nebank-cmyk-transparent-sm-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907050852-stark-moving-and-storage-strengthens-boston-presence-with-new-downtown-location-and-enhanced-local-moving-fleet</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T02:58:10+00:00</news:publication_date>
        <news:title>Stark Moving and Storage Strengthens Boston Presence with New Downtown Location and Enhanced Local Moving Fleet</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24466072-stark-movers-boston-220x78.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907153754-black-diamond-therapeutics-announces-oral-presentation-of-silevertinib-phase-2-data-in-frontline-egfrm-nsclc-patients-at-the-2026-asco-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T14:40:00+00:00</news:publication_date>
        <news:title>Black Diamond Therapeutics Announces Oral Presentation of Silevertinib Phase 2 Data in Frontline EGFRm NSCLC Patients at the 2026 ASCO Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b8da4d92-789b-4f0a-a1e2-2739af370155/small/bdtxlogo-pantone3135c-png-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907145614-dochub-expands-pdf-editing-capabilities-with-the-new-edit-text-feature</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T14:17:23+00:00</news:publication_date>
        <news:title>DocHub Expands PDF Editing Capabilities With The New Edit Text Feature  </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/73b52407-7228-4461-898e-10315d33abb0/medium/new-way-of-editing-in-dochub.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907144137-dewpoint-therapeutics-reports-preclinical-data-on-oral-myc-condensate-modulator-at-aacr-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T14:00:00+00:00</news:publication_date>
        <news:title>Dewpoint Therapeutics Reports Preclinical Data on Oral MYC Condensate Modulator at AACR 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e6f24195-bede-49a6-a925-b7dceea78e57/small/dewpoint-logo-centered-full-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907144160-disc-medicine-announces-oral-presentation-of-data-from-rally-mf-phase-2-trial-of-disc-0974-in-patients-with-myelofibrosis-and-anemia-at-the-american</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T14:00:00+00:00</news:publication_date>
        <news:title>Disc Medicine Announces Oral Presentation of Data from RALLY-MF Phase 2 Trial of DISC-0974 in Patients with Myelofibrosis and Anemia at the American Society of Clinical Oncology (ASCO) Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d212c899-9a87-4500-9382-573dfe9f12af/small/disc-logo-horiz-fullcolor-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907145037-progress-software-releases-2025-corporate-social-responsibility-report-underscoring-global-commitment-to-giving-back</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T14:00:00+00:00</news:publication_date>
        <news:title>Progress Software Releases 2025 Corporate Social Responsibility Report, Underscoring Global Commitment to Giving Back</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2a4a917f-af24-458f-b64e-25e5e5cc6c26/small/progress-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907137574-bevi-moves-beyond-water-unveils-brand-refresh-and-fully-connected-beverage-platform</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T13:05:00+00:00</news:publication_date>
        <news:title>Bevi Moves Beyond Water, Unveils Brand Refresh and Fully Connected Beverage Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7a0e868f-a0f4-425a-9ffd-2bd134bc8492/medium/bevi-announced-a-brand-refresh-new-products-that-diversify-b.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907134963-cangrade-adds-llm-choice-to-jules-ai-copilot-guided-by-ethical-ai</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T13:00:00+00:00</news:publication_date>
        <news:title>Cangrade Adds LLM Choice to Jules AI Copilot, Guided by Ethical AI</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e3bc045a-7a1f-466b-a408-e3ccd5ab2417/small/cangrade-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907135215-anaqua-sets-a-new-standard-for-modern-brand-protection-with-ai-driven-solutions</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T13:00:00+00:00</news:publication_date>
        <news:title>Anaqua Sets a New Standard for Modern Brand Protection with AI-driven Solutions</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907135833-akari-therapeutics-asco-abstract-acceptance-highlights-potential-for-aktx-101-adc-to-treat-kras-mutant-tumors</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T13:00:00+00:00</news:publication_date>
        <news:title>Akari Therapeutics ASCO Abstract Acceptance Highlights Potential for AKTX-101 ADC to Treat KRAS Mutant Tumors</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8d978f50-07a9-40a3-be69-45f51ccd94d9/small/akari-logo-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907126578-ipg-photonics-to-announce-first-quarter-2026-financial-results-on-may-5</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T12:00:00+00:00</news:publication_date>
        <news:title>IPG Photonics to Announce First Quarter 2026 Financial Results on May 5</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5825fb28-2af6-4779-82e4-989ded56e0a6/small/ipg-logo-jpg.JPG</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907127048-cogent-biosciences-announces-oral-presentation-of-positive-phase-3-peak-trial-in-gastrointestinal-stromal-tumors-gist-at-the-2026-american-society</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T12:00:00+00:00</news:publication_date>
        <news:title>Cogent Biosciences Announces Oral Presentation of Positive Phase 3 PEAK Trial in Gastrointestinal Stromal Tumors (GIST) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2b8cbfab-a4de-4e17-bdd6-7ef597a95d2e/small/cogent-biosciences-logo-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907128506-milliporesigma-launches-first-bio-based-solvent-portfolio-for-high-performance-liquid-chromatography</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T12:00:00+00:00</news:publication_date>
        <news:title>MilliporeSigma Launches First Bio-Based Solvent Portfolio for High-Performance Liquid Chromatography</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/Zjk3YzE3YjAtNjM2MC00MTc5LWJlM2MtMWQ5YjZhNWNhYWViLTUwMDE1NzEwMy0yMDI2LTA0LTIxLWVu/tiny/MilliporeSigma.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907127966-bpgbio-appoints-former-oxford-pro-vice-chancellor-for-innovation-chas-bountra-ph-d-as-executive-vice-president-and-chief-scientific-officer</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T11:05:00+00:00</news:publication_date>
        <news:title>BPGbio Appoints Former Oxford Pro-Vice Chancellor for Innovation Chas Bountra, Ph.D., as Executive Vice President and Chief Scientific Officer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4a0c4e8a-8478-4161-9bc1-cfcdc41c9462/medium/bpgbio-appoints-chas-bountra-ph-d-as-executive-vice-presiden.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907126696-standard-biotools-to-announce-first-quarter-2026-financial-results-on-may-5-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T11:00:00+00:00</news:publication_date>
        <news:title>Standard BioTools to Announce First Quarter 2026 Financial Results on May 5, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/122934c3-b763-4386-89d1-3047d0704c17/small/sbt-new-august-2022-logo.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907126754-vicor-corporation-reports-results-for-the-first-quarter-ended-march-31-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T11:00:00+00:00</news:publication_date>
        <news:title>Vicor Corporation Reports Results for the First Quarter Ended March 31, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/55117480-366f-4254-a0c3-1c89d863eb54/small/1200x628-4x-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907127978-kala-bio-celebrates-trump-executive-order-as-game-changer-for-psychedelic-medicine</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T11:00:00+00:00</news:publication_date>
        <news:title>Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/15db4366-93ba-40fa-b80d-58cbdde3496e/small/kala-bio-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907128135-aavantgarde-announces-completion-of-recruitment-in-stella-natural-history-study</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T11:00:00+00:00</news:publication_date>
        <news:title>AAVantgarde announces completion of recruitment in STELLA natural history study</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e7ffd915-8158-436d-b9fe-8db1cb3597ce/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907117621-hyalex-orthopaedics-announces-fda-510-k-clearance-of-the-hyalex-slalom-mtp-hemiarthroplasty-system</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-21T10:00:00+00:00</news:publication_date>
        <news:title>Hyalex Orthopaedics Announces FDA 510(k) Clearance of the HYALEX Slalom™ MTP Hemiarthroplasty System</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2c148840-120a-41be-af54-0ad73f8a4f6b/small/hyalex-logo-vector-recreated-white-border-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907002440-mayhew-tools-launches-new-3-pc-long-non-turning-pneumatic-set</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-20T21:03:19+00:00</news:publication_date>
        <news:title>Mayhew Tools Launches New 3 Pc. Long Non-Turning Pneumatic Set</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/22821933-mayhew-tools-2000x1260.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/906282724-heygears-unveils-one-stop-3d-printing-solutions-for-elastomer-transparent-engineering-applications-at-rapid-tct-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-20T16:00:00+00:00</news:publication_date>
        <news:title>HeyGears Unveils One-Stop 3D Printing Solutions for Elastomer, Transparent &amp; Engineering Applications at RAPID+TCT 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24835056-heygears-elastomer-3d-printing-1280x959.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907008228-aktualisierung-bvi-gibt-bekannt-dass-virtuoso-eine-neue-chirurgische-plattform-mit-doppelfunktion-die-ce-kennzeichnung-gem-eu-mdr-erhalten</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-20T21:28:54+00:00</news:publication_date>
        <news:title>AKTUALISIERUNG -- BVI gibt bekannt, dass Virtuoso®, eine neue chirurgische Plattform mit Doppelfunktion, die CE-Kennzeichnung gemäß EU-MDR erhalten hat</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NjNkNTUyMTQtMGZiYS00MTczLTkxNDYtN2IxMmI2YTU0ZmMyLTEyNjQwMzItMjAyNi0wNC0yMC1kZQ==/tiny/BVI-Medical-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907008243-mise-jour-bvi-annonce-l-obtention-du-marquage-ce-au-titre-du-r-glement-europ-en-sur-les-dispositifs-m-dicaux-pour-virtuoso-une-toute-nouvelle</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-20T21:28:54+00:00</news:publication_date>
        <news:title>MISE À JOUR -- BVI annonce l’obtention du marquage CE au titre du Règlement européen sur les dispositifs médicaux pour Virtuoso®, une toute nouvelle plateforme chirurgicale à double fonction</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NjNkNTUyMTQtMGZiYS00MTczLTkxNDYtN2IxMmI2YTU0ZmMyLTEyNjQwMzItMjAyNi0wNC0yMC1mcg==/tiny/BVI-Medical-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907000429-cargurus-to-report-first-quarter-2026-financial-results</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-20T20:05:00+00:00</news:publication_date>
        <news:title>CarGurus To Report First Quarter 2026 Financial Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5e9ed825-143d-405a-9794-acd1a1ded2cc/small/cg-logo-2025-small-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907000699-amwell-to-report-first-quarter-2026-operating-results</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-20T20:05:00+00:00</news:publication_date>
        <news:title>Amwell® to report first quarter 2026 operating results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ff1989f5-0a6a-4e00-99dc-cb29a818aca5/small/amwell-logo-blue-2023-v02-rgb-2-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907001167-kailera-announces-closing-of-initial-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-20T20:05:00+00:00</news:publication_date>
        <news:title>Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c0b33a3d-0c2b-45b0-ace8-6ff585b41339/small/kailera-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907000519-flywire-to-announce-first-quarter-2026-earnings-on-may-5-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-20T20:00:00+00:00</news:publication_date>
        <news:title>Flywire to Announce First Quarter 2026 Earnings on May 5, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9b1123f3-5f90-4036-ab7b-c4c3d1f5491b/small/flywire-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/906982674-lung-cancer-therapeutics-market-to-reach-49-5-billion-by-2030-driven-by-rising-cancer-incidence-and-r-d-investment-surge</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-20T18:19:26+00:00</news:publication_date>
        <news:title>Lung Cancer Therapeutics Market to Reach $49.5 Billion by 2030, Driven by Rising Cancer Incidence and R&amp;D Investment Surge</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/906954630-bvi-announces-ce-mark-under-eu-mdr-for-virtuoso-a-brand-new-dual-function-surgical-platform</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-20T14:00:00+00:00</news:publication_date>
        <news:title>BVI Announces CE Mark Under EU MDR for Virtuoso®, A Brand New Dual-Function Surgical Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0e7f0025-cd6d-4b42-9d31-9d16f1b74c40/small/bvi-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/906950148-hinweis-zum-nichtbeachten-bvi-medical-inc</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-20T13:46:44+00:00</news:publication_date>
        <news:title>HINWEIS ZUM NICHTBEACHTEN -- BVI Medical, Inc.</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0e7f0025-cd6d-4b42-9d31-9d16f1b74c40/small/bvi-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/906950152-avis-ignorer-bvi-medical-inc</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-20T13:46:44+00:00</news:publication_date>
        <news:title>AVIS À IGNORER -- BVI Medical, Inc.</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0e7f0025-cd6d-4b42-9d31-9d16f1b74c40/small/bvi-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/906945990-payscale-intelligence-cloud-sets-new-standard-in-compensation-intelligence</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-20T13:00:00+00:00</news:publication_date>
        <news:title>Payscale Intelligence Cloud Sets New Standard in Compensation Intelligence</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8d98e996-808c-4de5-8b7e-15bec433c6f4/small/payscale-full-logo-dark-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/906946091-immuneering-presents-genetic-data-at-aacr-annual-meeting-demonstrating-mechanism-to-improve-durability-and-survival-supporting-use-of-atebimetinib-in</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-20T13:00:00+00:00</news:publication_date>
        <news:title>Immuneering Presents Genetic Data at AACR Annual Meeting Demonstrating Mechanism to Improve Durability and Survival, Supporting Use of Atebimetinib in First-Line Pancreatic Cancer and Beyond</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/81d0c83f-ae53-4d6e-9c5e-d6963e02f29d/small/immuneering-logo-cropped-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/906946361-velocity-logic-group-and-paytronix-partner-to-extend-loyalty-engagement-to-every-pump-transaction</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-20T13:00:00+00:00</news:publication_date>
        <news:title>Velocity Logic Group and Paytronix Partner to Extend Loyalty Engagement to Every Pump Transaction</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a0a47d40-4419-436d-b187-246e25669b64/small/access-paytronix-dark-002-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/906941093-akari-therapeutics-reports-positive-preclinical-data-for-aktx-101-demonstrating-differentiated-cytotoxicity-for-first-in-class-trop2-adc-payload</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-20T12:35:00+00:00</news:publication_date>
        <news:title>Akari Therapeutics Reports Positive Preclinical Data for AKTX-101 Demonstrating Differentiated Cytotoxicity for First-in-Class TROP2 ADC Payload Targeting RNA Splicing</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8d978f50-07a9-40a3-be69-45f51ccd94d9/small/akari-logo-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/906936761-fulcrum-therapeutics-to-host-first-quarter-2026-financial-results-conference-call-and-webcast-on-monday-april-27-2026-at-8-00-a-m-et</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-20T12:00:00+00:00</news:publication_date>
        <news:title>Fulcrum Therapeutics to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, April 27, 2026, at 8:00 a.m. ET</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3434fc83-4bcf-4d3c-ae26-23e5b1fd4252/small/fulcrum-logo-primary-full-color-rgb-large-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/906937116-bvi-gibt-bekannt-dass-virtuoso-eine-neue-chirurgische-plattform-mit-doppelfunktion-die-ce-kennzeichnung-gem-eu-mdr-erhalten-hat</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-20T12:00:00+00:00</news:publication_date>
        <news:title>BVI gibt bekannt, dass Virtuoso®, eine neue chirurgische Plattform mit Doppelfunktion, die CE-Kennzeichnung gemäß EU-MDR erhalten hat</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0e7f0025-cd6d-4b42-9d31-9d16f1b74c40/small/bvi-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/906937119-bvi-annonce-l-obtention-du-marquage-ce-au-titre-du-r-glement-europ-en-sur-les-dispositifs-m-dicaux-pour-virtuoso-une-toute-nouvelle-plateforme</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-20T12:00:00+00:00</news:publication_date>
        <news:title>BVI annonce l’obtention du marquage CE au titre du Règlement européen sur les dispositifs médicaux pour Virtuoso®, une toute nouvelle plateforme chirurgicale à double fonction</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0e7f0025-cd6d-4b42-9d31-9d16f1b74c40/small/bvi-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/906932351-biogen-enters-into-agreement-with-tj-biopharma-for-felzartamab-assets-in-the-greater-china-region</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-20T11:30:00+00:00</news:publication_date>
        <news:title>Biogen Enters into Agreement with TJ Biopharma for Felzartamab Assets in the Greater China Region</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/80f9c524-3da2-4583-a763-0dad931fa182/small/biogen-logo-standard-rgb-r-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/906931981-seres-therapeutics-showcases-ser-155-data-and-live-biotherapeutic-insights-at-escmid-global-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-20T11:00:00+00:00</news:publication_date>
        <news:title>Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f8c3ad50-d1a3-457d-b0c7-8f9237db7f93/small/seres-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/906932245-monte-rosa-therapeutics-presents-preclinical-data-at-american-association-for-cancer-research-aacr-annual-meeting-2026-on-the-potential-of-its</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-20T11:00:00+00:00</news:publication_date>
        <news:title>Monte Rosa Therapeutics Presents Preclinical Data at American Association for Cancer Research (AACR) Annual Meeting 2026 on the Potential of its Cyclin E1 (CCNE1)-directed Molecular Glue Degrader to Treat CCNE1-amplified Solid Tumors</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/20ed9999-454a-4e2a-aabc-217270a87d2d/small/mrtx-logo-primaryblue-4cp-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/906932319-seres-therapeutics-showcases-ser-155-data-and-live-biotherapeutic-insights-at-escmid-global-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-20T11:00:00+00:00</news:publication_date>
        <news:title>Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f8c3ad50-d1a3-457d-b0c7-8f9237db7f93/small/seres-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/906891444-schneider-electric-and-deloitte-collaborate-to-drive-ai-enabled-digital-transformation-across-industrial-operations</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-20T06:00:00+00:00</news:publication_date>
        <news:title>Schneider Electric and Deloitte collaborate to drive AI-enabled digital transformation across industrial operations</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5d185555-b771-4931-ba37-33a6fc1f5d24/medium/schneider-electric-and-deloitte-collaborate-to-drive-ai-enab.jpg</image:loc>
        </image:image>
    </url>
</urlset>
